Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vericel Corp (NASDAQ:VCEL)

2.80
Delayed Data
As of 3:59pm ET
 -0.05 / -1.75%
Today’s Change
1.69
Today|||52-Week Range
6.69
+8.53%
Year-to-Date
No recent news for Vericel Corp.

Today’s Trading

Previous close2.85
Today’s open2.87
Day’s range2.80 - 2.94
Volume265,755
Average volume (3 months)169,505
Market cap$68.4M
Dividend yield--
Data as of 3:59pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)+56.50%
Earnings growth (this year)+6.70%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+77.69%
P/E ratioNM
Price/Sales1.20
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ADMPAdamis Pharmaceutica...+0.17+5.21%
MBRXMoleculin Biotech In...-0.38-6.24%
AVEOAveo Pharmaceuticals...+0.00+0.01%
ADHDAlcobra Ltd-0.04-1.59%
Data as of 4:00pm ET, 09/30/2016

Financials

Next reporting dateNovember 11, 2016
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$51.2M
Annual profit (last year)-$16.3M
Net profit margin-31.93%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Dominick C. Colangelo
Chief Operating Officer
Daniel R. Orlando
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Search for Jobs